| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |